We are looking for children and teens 2–17 years of age to join a Crohn’s disease clinical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or Crohn’s disease (CD) (including associated symptoms such as rectal bleeding, stomach pain, constant need to poop, frequent fevers and/or anemia), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
